These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16835079)

  • 21. Hormone therapy. An update on risks and benefits.
    Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
    [No Abstract]   [Full Text] [Related]  

  • 22. Menopause: refining benefits and risks of hormone replacement therapy.
    Cooper A; Whitehead M
    Curr Opin Obstet Gynecol; 1995 Jun; 7(3):214-9. PubMed ID: 7647275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone therapy--weighing up the evidence.
    Teede HJ
    Aust Fam Physician; 2004 Nov; 33(11):875-80. PubMed ID: 15584324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of hormone therapy and breast cancer.
    Norman RJ; MacLennan AH
    Hum Reprod Update; 2005; 11(6):541-3. PubMed ID: 16150811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
    van de Weijer PH; Mattsson LA; Ylikorkala O
    Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal hormone therapy and risk of breast cancer.
    Chen FP
    Chang Gung Med J; 2009; 32(2):140-7. PubMed ID: 19403003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone replacement therapy: real concerns and false alarms.
    Bluming AZ; Tavris C
    Cancer J; 2009; 15(2):93-104. PubMed ID: 19390302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone replacement therapy and the risk of breast cancer.
    Cuzick J
    Eur J Cancer; 2008 Nov; 44(16):2344-9. PubMed ID: 18783940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone replacement therapy. Indications, benefits and risk.
    Davis S
    Aust Fam Physician; 1999 May; 28(5):437-45. PubMed ID: 10376367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy.
    Genazzani AR; Schneider HP; Panay N; Nijland EA
    Gynecol Endocrinol; 2006 Jul; 22(7):369-75. PubMed ID: 16864146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progestogen use in women approaching the menopause and breast cancer risk.
    Campagnoli C; Ambroggio S; Lotano MR; Peris C
    Maturitas; 2009 Apr; 62(4):338-42. PubMed ID: 19118958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there a place for postmenopausal hormone therapy use in women with lupus?
    Gompel A; Piette JC
    Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L; Dell'Aniello S; Assouline S; Suissa S
    BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 35. [Expert meeting on the effect of sex hormones on the normal breast: moderately increased risk of cancer, but the connection is still not clear].
    von Schoultz B; Bergkvist L; Magnusson C; von Schoultz E
    Lakartidningen; 2000 May; 97(18):2225-6. PubMed ID: 10850053
    [No Abstract]   [Full Text] [Related]  

  • 36. The medical management of menopause: to treat or not to treat?
    Barlow DH
    Ann N Y Acad Sci; 2008 Apr; 1127():134-9. PubMed ID: 18443341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risks and benefits of hormone therapy: has medical dogma now been overturned?
    Shapiro S; de Villiers TJ; Pines A; Sturdee DW; Baber RJ; Panay N; Stevenson JC; Mueck AO; Burger HG
    Climacteric; 2014 Jun; 17(3):215-22. PubMed ID: 24654673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone replacement therapy: the right choice for your patient?
    Leong SL; Erickson DR; Pees RC
    J Fam Pract; 2005 May; 54(5):428-36. PubMed ID: 15865901
    [No Abstract]   [Full Text] [Related]  

  • 39. Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.
    Johansen OE; Qvigstad E
    Adv Ther; 2008 Jun; 25(6):525-51. PubMed ID: 18568306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone replacement after breast cancer: is it safe?
    Liotta M; Escobar PF
    Clin Obstet Gynecol; 2011 Mar; 54(1):173-9. PubMed ID: 21278517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.